Skip to content

To evaluate the effect of propofol combined with dexmedetomidine and remifentanil in ultrasound gastroenteroscopy

Comparing propofol combined with dexmedetomidine and remifentanil in ultrasound gastroenteroscopy: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050074
Enrollment
Unknown
Registered
2021-08-16
Start date
2021-08-10
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal disease

Interventions

group PD :Propofol combined with dexmedetomidine
group PR :Propofol combined with remifentanil

Sponsors

Affiliated Cancer Hospital of Shandong First Medical University, Shandong Cancer Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged 18–75 years, with ASA (American Society of Anesthesiology) I–III, and scheduled for painless endoscopic ultrasonography.

Exclusion criteria

Exclusion criteria: 1. BMI>25 kg/m^2 or < 18 kg/m^2; 2. Pregnancy; 3. There are serious complications (such as: heart failure, respiratory failure, liver or kidney failure), heart conduction disease bradycardia, or abnormal rhythm; 4. History of asthma or chronic bronchitis, upper respiratory tract infection within the past 2 weeks, obstructive sleep apnea; 5. Allergic to the drugs used in the research; 6. History of drug abuse.

Design outcomes

Primary

MeasureTime frame
endoscopy physician satisfaction;

Secondary

MeasureTime frame
patient satisfaction;induction time;time of reached the standard for discharge;body movement;cardiopulmonary adverse event;

Countries

China

Contacts

Public ContactWang Xiuqin

Affiliated Cancer Hospital of Shandong First Medical University, Shandong Cancer Institute

wangxiuqin_sd@sina.com+86 13665416586

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026